U.S. Pharma Stock News

Wondering whether Genco Shipping & Trading's current share price reflects its true worth, or if the market is missing something? The stock last closed at US$24.32, with returns of 4.7% over 7 days, 12.7% over 30 days, 31.9% year to date and 104.9% over the past year. This raises questions about how much of the story is already in the price. Recent coverage has focused on Genco Shipping & Trading's position within the shipping sector and how investors are reacting to changing sentiment around...

Wondering whether OSI Systems at around US$288 a share still represents value, or if most of the opportunity is already priced in? This article walks through the key signals to help you frame that question for yourself. The stock has recent returns of 9.4% over 7 days, 2.2% over 30 days, 12.9% year to date, 50.9% over 1 year, 180.6% over 3 years and 198.6% over 5 years, which naturally raises questions about where valuation stands today. Recent coverage has kept attention on OSI Systems,...

Brookfield Wealth Solutions, listed as NYSE:BNT, is in focus as its parent company prepares a $1b transfer of Brookfield Business Corporation shares. The company has also completed a major acquisition of Just Group, adding substantially to its global insurance assets under management. These actions represent a material shift in Brookfield Wealth Solutions' structure and exposure, going beyond routine financial updates. For you as an investor, these moves matter because Brookfield Wealth...

DXC Technology (NYSE:DXC) has entered a multi year partnership with ServiceNow to roll out ServiceNow’s new agentic AI tools across DXC’s core business operations. DXC will act as "Customer Zero" for ServiceNow’s Core Business Suite, using the platform internally before it is broadly offered to clients. The collaboration is aimed at deploying scalable AI led automation and more streamlined enterprise functions for DXC and its customers. For investors watching NYSE:DXC, this partnership...

If you are wondering whether Ultragenyx Pharmaceutical at US$23.15 is a bargain or a value trap, the key is understanding what the current price actually implies about the business. The stock has returned 8.1% over the last week and 2.4% over the last month, but is still showing a 1.9% decline year to date and a 31.7% decline over the last year, with even deeper 3 year and 5 year returns of 38.3% and 78.6% respectively. These moves sit against a backdrop of ongoing interest in rare disease...

Why PriceSmart's Latest Earnings Are Back in Focus PriceSmart (PSMT) is back on investors’ radar after reporting fiscal second quarter results that showed higher revenue and net income year over year, alongside plans for new clubs and supply chain upgrades across its markets. See our latest analysis for PriceSmart. The earnings release and club expansion plans appear to have coincided with stronger trading interest, with a 27.1% year to date share price return and an 84.5% one year total...

Investors may be wondering whether Affiliated Managers Group at around US$286.48 is still offering value, or if most of the easy gains are already on the table. The stock has moved 4.7% over the last 7 days and 1.8% over the last 30 days, with a 79.3% return over 1 year, 106.1% over 3 years and 83.0% over 5 years, even though the year to date return sits at a slight 0.8% decline. Recent coverage has focused on how asset managers are positioning for changing investor preferences and capital...

If you are wondering whether Wendy's current share price really reflects what the business is worth, this breakdown will help you connect the recent moves in the stock to what the underlying valuation signals are saying. The share price recently closed at US$7.06, with returns of 2.3% over 7 days, a 2.9% decline over 30 days, a 13.6% decline year to date, and a 42.8% decline over the past year, which may have shifted how investors view both risk and potential upside. Recent coverage around...

Virgin Galactic Holdings recently filed a US$1.35 million shelf registration for 555,000 shares tied to its employee stock plan and reported fourth-quarter 2025 sales of US$312,000 alongside a net loss of US$62.72 million. At the same time, the company has reopened US$750,000-per-seat ticket sales and advanced its Delta-class spacecraft toward testing, highlighting a push to align capital, talent and product readiness ahead of a planned return to commercial service. We’ll now examine how the...

Mid-America Apartment Communities (MAA) is back in focus as analysts update their views, the REIT prepares to report upcoming earnings, and insiders execute planned share sales alongside a recently confirmed quarterly dividend. See our latest analysis for Mid-America Apartment Communities. The recent 1-day share price return of 1.44% and 7-day gain of 2.89% to US$126.09 sit against a weaker backdrop, with a 30-day share price return of 4.58% and a 1-year total shareholder return of 16.66%...

Kura Sushi USA (KRUS) opened Q2 2026 with revenue of US$80.0 million, a basic EPS loss of US$0.14, and net income loss of US$1.7 million, setting the tone for another quarter where top line growth is front and center while profitability remains under pressure. The company has reported quarterly revenue increasing from US$64.9 million in Q2 2025 to US$80.0 million in Q2 2026, while basic EPS moved from a loss of US$0.31 to a loss of US$0.14 over the same period, alongside a trailing twelve...

AI runs on real world hardware, and right now that physical backbone is where a lot of the attention is going. While energy prices, interest rate expectations, and geopolitical tensions are keeping many sectors on edge, the companies building data centers, power connections, and cooling systems are dealing in tangible demand. The AI Infrastructure Stocks screener focuses on those providers that are turning sales into cash flow, instead of just selling a story. In this article, you will see 3...

Markets are being pulled in different directions by energy prices, interest rate expectations, and shifting inflation trends, and that can make it harder to know where to focus. One clear anchor is leadership that is deeply invested in its own business. Founder led companies, where leaders typically hold meaningful stakes and think in decades rather than quarters, can offer a different quality of commitment. This article looks at our Top Founder Led Companies screener and highlights three...

Nurix Therapeutics (NRIX) opened 2026 with Q1 revenue of US$6.3 million and a basic EPS loss of US$0.79, while trailing twelve month figures show revenue of US$71.8 million against a basic EPS loss of US$3.17, framing a business that is still firmly in investment mode. Over the past year, the company has seen quarterly revenue range from US$6.3 million to US$44.1 million and basic EPS move between a loss of US$0.52 and a loss of US$1.03, giving investors a clear view of how top line progress...

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) has launched Heart’s Home, a Direct-to-Consumer campaign focused on ARCALYST for recurrent pericarditis. The campaign aims to expand awareness and empower patients about the only FDA approved therapy for recurrent pericarditis. Heart’s Home represents a new commercial effort to reach patients directly outside the traditional physician focused model. Kiniksa Pharmaceuticals International, listed on NasdaqGS:KNSA, develops and...

BOK Financial (NasdaqGS:BOKF) has promoted Scott Andrews to lead its Specialized Industries Banking group. The appointment follows the planned retirement of Executive Vice President Brad Vincent. The transition affects key lines of business including commercial real estate, energy, and healthcare banking. BOK Financial’s Specialized Industries Banking unit sits at the core of its commercial franchise, with exposure to sectors that tend to be closely watched by lenders and regulators. Areas...

Aehr Test Systems (AEHR) has released its Q3 2026 numbers, reporting revenue of US$10.3 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$3.2 million loss. The company has seen quarterly revenue move between US$13.5 million and US$18.3 million since Q2 2025, while basic EPS has ranged from a profit of US$0.78 per share on a trailing twelve month basis in 2025 to a loss of US$0.38 per share over the most recent twelve month window. This keeps the focus...

If you are wondering whether PagSeguro Digital's current share price truly reflects its underlying worth, this article walks through the key signals you can use to judge that. The stock recently closed at US$10.76, with returns of 2.2% over the last 7 days, 7.8% over 30 days, 11.3% year to date, 35.4% over 1 year, 31.3% over 3 years and a 75.3% decline over 5 years. Recent coverage has focused on PagSeguro Digital's position within diversified financials and how changing views on digital...

Event context and recent price action HeartFlow (HTFL) has attracted fresh attention after a recent uptick in its share price, building on a 0.8% gain over the past day and a 10.5% move across the past week. That short term strength sits alongside a 16.8% rise over the past month, set against a 19.1% decline across the past 3 months and a 6.5% negative return year to date. Together, these figures give investors a mixed recent picture. See our latest analysis for HeartFlow. Putting that into...

Nadia Karkar has left TPG Rise to become a Managing Partner at 500 Global. She previously led global business development and TPG Rise's Global South Initiative. Her departure affects TPG's climate focused investing and relationships in emerging markets. TPG, traded as NasdaqGS:TPG, is in the spotlight after this leadership change within its impact investing arm. The shares most recently closed at $38.26, with a 3 year return of 47.4% and a 1 year return of a 13.4% decline. The stock is...

If you are wondering whether CoreWeave's current share price still offers value, this breakdown will help you weigh what you are paying against what you are getting. The stock last closed at US$88.90, with returns of 13.3% over 7 days, 19.5% over 30 days, 12.1% year to date, and 82.3% over 1 year. These returns have likely caught the attention of both new and existing investors who are reassessing risk and reward. Recent coverage has focused on CoreWeave's role in AI infrastructure and its...

Why Confluent (CFLT) is in focus now Confluent (CFLT) is back in the spotlight after disclosing reduced cloud usage from a major AI native customer and facing an investor investigation into possible securities law violations and related business conduct. See our latest analysis for Confluent. After the disclosure about reduced cloud usage and the legal probe, investors have already experienced some volatility, yet Confluent’s 16.94% 1 year total shareholder return and 48.99% 3 year total...

RPM International (RPM) just posted Q3 2026 results with revenue of US$1.6b and basic EPS of US$0.40, alongside net income excluding extra items of US$51.4m, putting fresh numbers around a year that also includes trailing 12 month revenue of US$7.7b and EPS of US$5.21. Over the past few quarters, the company has seen revenue move from US$1.48b in Q3 2025 to US$2.11b in Q1 2026 before landing at US$1.61b in the latest quarter. Basic EPS has ranged from around US$0.41 to US$1.78 across that...

In early April 2026, Citigroup downgraded Bio-Rad Laboratories’ rating from “Buy” to “Neutral,” signaling a shift in analyst sentiment toward the life science and clinical diagnostics company. This reassessment comes as Bio-Rad is cited among key players in the rapidly expanding single-cell omics market, where demand for advanced tools in cancer, immunology, and stem cell research is intensifying. We’ll now examine how Citigroup’s downgrade, against a backdrop of growing single-cell omics...